Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot of a bowel habit assessment tool to enable early identification of <i>Clostridioides difficile</i> infection.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2024
Same author

Primary Care Evaluation of a Hepatitis C Virus (HCV) Screening Education Intervention.

Journal of the American Board of Family Medicine : JABFM·2022
Same author

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence.

The American journal of gastroenterology·2021
Same author

Novel Models to Identify Census Tracts for Hepatitis C Screening Interventions.

Journal of the American Board of Family Medicine : JABFM·2020
Same author

Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection.

Liver international : official journal of the International Association for the Study of the Liver·2019
Same author

Impact of hepatitis C virus eradication on hepatocellular carcinoma rates.

Clinical liver disease·2019

Related Experiment Video

Updated: Jul 1, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

40.9K

Interpretation of HBV Serologies.

Philippe J Zamor1, Ashley M Lane2

  • 1Division of Hepatology, Carolinas Medical Center-Atrium Healthcare, 1025 Morehead Medical Drive, Charlotte, NC 28204, USA.

Clinics in Liver Disease
|October 1, 2021
PubMed
Summary

Hepatitis B virus (HBV) infection detection, serologies, and genotypes are reviewed. Understanding HBV markers and mutations is crucial for managing disease progression and treatment.

Keywords:
Acute HBVAnti-HBcChronic HBVHBV DNAHBeAg-NegativeHBeAg-PositiveHBsAg

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.1K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.9K

Related Experiment Videos

Last Updated: Jul 1, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

40.9K
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

3.1K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.9K

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis B was discovered during investigations into transfusion-associated jaundice.
  • Hepatitis B virus (HBV) was identified through extensive research efforts.
  • Understanding HBV's origins and transmission is key to public health.

Purpose of the Study:

  • To review diagnostic tests for detecting HBV infection (past or active).
  • To discuss the significance of Hepatitis B surface antigen as a treatment endpoint.
  • To explore the global distribution and clinical impact of various HBV genotypes.

Main Methods:

  • Review of existing literature on HBV serologies and diagnostics.
  • Analysis of HBV genotypes and their association with disease progression.
  • Examination of HBV mutations and their clinical significance.

Main Results:

  • Specific tests accurately detect HBV exposure and active infection.
  • Hepatitis B surface antigen is a valuable tool for defining treatment success.
  • HBV genotype C is linked to increased hepatocellular carcinoma risk.
  • HBV serologies and DNA levels correlate with disease progression.

Conclusions:

  • Comprehensive understanding of HBV serologies, genotypes, and mutations is essential for effective patient management.
  • Monitoring infected individuals requires specific recommendations based on disease markers.
  • Further research into HBV pathogenesis and treatment strategies is warranted.